Kawasaki et al.
2-Phenoxyacetylamino-9-[5′-O-dimethoxytrityl-3-O-
(N,N-diisopropyl-2-cyanoethylphosphoramidyl)-2′-deoxy-
D-ribofranosyl]-6-(2-methylthioethyl)purine (8). A solu-
tion of 7 (310 mg, 0.67 mmol) in dry pyridine (3.0 mL) was
stirred for 1 h in the presence of 4 Å molecular sieves at 0 °C.
Then dimethoxytrityl chloride (343 mg, 1.0 mmol) was added
into the solution and the mixture was stirred for 2 h. The
resulting mixture was diluted with chloroform (30 mL) and
washed with saturated aqueous NaHCO3, H2O, and brine. The
organic layer was dried over anhydrous Na2SO4, filtered, and
concentrated under reduced pressure. The residue was purified
by silica gel chromatography (chloroform-MeOH 95:5, 0.5%
pyridine, v/v) to afford 2-phenoxyacetylamino-9-(5-O-dimethoxy-
trityl-2′-deoxy-D-ribofranosyl)-6-(2-methylthioethyl)purine as
a colorless oil (500 mg, 0.61 mmol, 90%): 1H NMR (CDCl3,
400 MHz) δ 8.93 (1H, br s), 8.11 (1H, s), 7.68-7.00 (14H, m),
6.79-6.73 (4H, m), 6.56 (1H, t, J ) 6.3 Hz), 4.87 (1H, dt, J )
5.9, 3.0 Hz), 4.68 (2H, br s), 4.17 (1H, m), 3.75 (6H, s), 3.48-
3.33 (4H, m), 3.06 (2H, t, J ) 6.9 Hz), 2.87-2.57 (2H, m), 2.18
(3H, s); FABMS (m/z) 761 (M)+.
To a solution of the above product (110 mg, 0.14 mmol) in
dry dichloromethane (3.0 mL) was added diisopropylethyl-
amine (0.15 mL, 0.86 mmol) at 0 °C in the presence of 4 Å
molecular sieves. After the resulting mixture was stirred for
30 min, 2-cyanoethyl N,N-diisopropylchlorophosphoramidite
(0.11 mL, 0.43 mmol) was added. The reaction mixture was
stirred for an additional 30 min at the same temperature. The
resulting mixture was diluted with ethyl acetate (30 mL) and
washed with saturated aqueous NH4Cl, H2O, and brine. The
organic layer was dried over anhydrous Na2SO4, filtered, and
concentrated under reduced pressure. The residue was purified
by silica gel chromatography (hexanes-ethyl acetate 1:1, v/v)
to afford 8 as a colorless oil (123 mg, 0.13 mmol, 93%). 1H NMR
(CDCl3, 400 MHz) δ 8.81 (1H, br s), 8.14 (1H, s), 7.39-7.01
(14H, m), 6.76 (4H, dd, J ) 6.8, 2.0 Hz), 6.47 (1H, t, J ) 6.3
Hz), 4.78 (3H, m), 4.29 (1H, m), 3.88-3.78 (2H, m), 3.76 (6H,
s), 3.74-3.56 (4H, m), 3.47-3.32 (2H, m), 3.37 (2H, t, J ) 6.3
Hz), 2.88-2.60 (2H, m), 2.64 (2H, t, J ) 6.3 Hz), 2.18 (3H, s),
1.19 (6H, d, J ) 6.9 Hz), 1.17 (6H, d, J ) 6.9 Hz); 31P NMR
(CDCl3, 162 MHz) δ 148.8; FABMS (m/z) 962 (M)+.
Although detailed mechanisms of the activation process
are still uncertain, stability, selectivity, and reactivity
of the new cross-linking agents will be beneficial to
antisense and antigene methods, and their biological
applications are now in progress.
Experimental Section
2-Amino-9-(3′,5′-di-O-tert-butyldimethylsilyl-2′-deoxy-
D-ribofranosyl)-6-(2-methylthioethyl)purine (5). To a so-
lution of 2-amino-9-(3,5-di-O-tert-butyldimethylsilyl- 2′-deoxy-
D-ribofranosyl)-6-vinylpurine (1) (1.1 g, 2.2 mmol) in CH3CN
(10 mL) was added methylmercaptane sodium salt (15% in
water) (1.2 mL, 2.6 mmol) at room temperature. After being
stirred for 20 min, the reaction mixture was diluted with ethyl
acetate (50 mL), then washed with H2O and brine. The organic
layer was dried over anhydrous Na2SO4, filtered, and concen-
trated under reduced pressure. The residue was purified by
silica gel chromatography (chloroform-methanol 97:3, v/v) to
afford 5 as a pale yellow oil (1.1 g, 2.03 mmol, 93%): IR (neat)
1
3400, 1600 cm-1; H NMR (CDCl3, 400 MHz) δ 8.02 (1H, s),
6.32 (1H, t, J ) 6.3 Hz), 5.21 (2H, br s), 4.58 (1H, dt, J ) 5.6,
3.0 Hz), 3.99 (1H, dd, J ) 6.9, 3.3 Hz), 3.77 (2H, m), 3.33 (2H,
t, J ) 6.6 Hz), 3.03 (2H, t, J ) 6.6 Hz), 2.65-2.32 (2H, m),
2.18 (3H, s), 0.90 (18H, s), 0.10 (12H, s); 13C NMR (125 MHz,
CDCl3) δ -5.5, -5.4, -4.8, -4.7, 15.4, 18.0, 18.4, 25.7, 25.9,
32.0, 32.9, 40.6, 62.8, 72.1, 83.5, 87.6, 127.3, 139.3, 152.4, 159.5,
161.3; FABMS (m/z) 554 (M + 1)+; HRFABMS calcd for
C25H48N5O3Si2S 554.3016, found 554.3066.
2-Phenoxyacetylamino-9-(3′,5′-di-O-tert-butyldimeth-
ylsilyl-2′-deoxy-D-ribofranosyl)-6-(2-methylthioethyl)pu-
rine (6). To a solution of 5 (800 mg, 1.45 mmol) in dry CH3CN
(3.0 mL) was added 1-hydroxybenzotriazole (490 mg, 4.3 mmol)
in dry pyridine solution (3.0 mL) in the presence of 4 Å
molecular sieves at room temperature. After the resulting
mixture was stirred for 1 h, freshly distilled phenoxyacetyl
chloride (0.62 mL, 4.3 mmol) was added slowly to the reaction
mixture. The reaction mixture was stirred for an additional 3
h, diluted with ethyl acetate (50 mL), and washed with H2O
and brine. The organic layer was dried over anhydrous Na2-
SO4, filtered, and concentrated under reduced pressure. The
residue was purified by silica gel chromatography (hexanes-
ethyl acetate 7:3, v/v) to give 6 as a pale yellow oil (747 mg,
Oligonucleotide Synthesis. All oligonucleotides were
synthesized at a 1 µmol scale on Cyclon Plus DNA-synthesizer
(Milligen/Biosearch) with standard â-cyanoethyl phosphora-
midite chemistry. The 5′-terminal dimethoxytrityl-bearing
ODNs were removed from the solid support by treatment with
0.1 M NaOH (2.0 mL) and the solution was neutralized with
CH3COOH instantly. The crude product was purified by
reverse-phase HPLC with C-18 column (nacalai tesque: COS-
MOSIL 5C18-AR-II, 10 × 250 mm) by a linear gradient of 10-
40%/20 min of acetonitrile in 0.1 M TEA buffer at a flow rate
of 4 mL/min. The dimethoxytrityl group of the purified ODN
was cleaved with 10% AcOH and the mixture was additionally
purified by HPLC with the same elution method. MALDI-TOF
MS (m/z) 9: calcd 4812.83, found 4809.78
1
1.09 mmol, 75%): IR (neat) 3400, 1720, 1600 cm-1; H NMR
(CDCl3, 400 MHz) δ 8.90 (1H, br s), 8.25 (1H, s), 7.38-7.31
(2H, m), 7.08-7.01 (3H, m), 6.47 (1H, t, J ) 6.6 Hz), 4.79 (2H,
br s), 4.64 (1H, dt, J ) 5.6, 3.0 Hz), 4.00 (1H, dd, J ) 7.3, 3.3
Hz), 3.88 (1H, dd, J ) 11.2, 3.3 Hz), 3.77 (1H, dd, J ) 11.2,
3.3 Hz), 3.44 (2H, t, J ) 7.3 Hz), 3.07 (2H, t, J ) 7.3 Hz), 2.73-
2.44 (2H, m), 2.18 (3H, s), 0.91 (18H, s), 0.10 (12H, s); 13C NMR
(125 MHz, CDCl3) δ -5.5, -5.4, -4.8, -4.7, 15.4, 18.0, 18.4,
25.7, 25.9, 31.8, 32.7, 40.9, 62.8, 68.0, 72.0, 84.2, 88.0, 114.9,
122.2, 129.7, 130.5, 142.4, 151.3, 151.5, 157.1, 161.5, 166.3;
FABMS (m/z) 688 (M + 1)+.
Preparation of the ODN 10. To a solution of ODN 9 (0.97
µmol, 1 mL) was added a solution of magnesium monoper-
phthalate (MMPP) (2.9 µmol) in carbonate buffer (50 µL)
adjusted to pH 10 at room temperature. After 30 min, NaOH
(4 mol/L, 150 µL) was added, and the mixture was left for an
additional 30 min. The resulting mixture was dialyzed with a
buffer (0.1 M NaCl, 5 mM potassium phosphate, pH 7.0) to
give ODN (9) (0.75 µmol). MALDI-TOF MS (m/z) 10: calcd
4764.83, found 4762.97.
Preparation of the ODN 11a-l. To a solution of ODN 10
(0.41 µmol, 1.0 mL) was added a solution of substituted
thiophenol in CH3CN (2.1 µmol, 20 µL) at room temperature.
After 30 min, the resulting mixture was purified by HPLC to
give ODN 11a-l. The yields and MALDI-TOF MS (m/z) date
of 11a-l are summarized in Table 2.
2-Phenoxyacetylamino-9-(2′-deoxy-D-ribofranosyl)-6-
(2-methylthioethyl)purine (7). To a solution of 6 (600 mg,
0.87 mmol) in dry THF solution (1.0 mL) was added n-Bu4NF
in THF solution (1.0 M solution, 2.62 mmol, 2.62 mL) at 0 °C.
After 1 h, the reaction mixture was concentrated under
reduced pressure. The residue was purified by silica gel
chromatography (CHCl3-MeOH 95:5, v/v) to give the diol 7
as a colorless crystal (392 mg, 0.85 mmol, 98%): mp 158 °C;
IR (neat) 3400, 1720, 1600 cm-1; 1H NMR (d-DMSO, 400 MHz)
δ 9.10 (1H, br s), 8.03 (1H, s), 7.38-7.31 (2H, m), 7.08-7.01
(3H, m), 6.31 (1H, t, J ) 6.3 Hz), 5.10 (1H, m), 4.70 (2H, s),
4.15 (1H, dd, J ) 5.6, 2.6 Hz), 3.90 (1H, m), 3.43 (2H, t, J )
7.3 Hz), 3.07 (2H, t, J ) 7.3 Hz), 3.03 (1H, m), 2.41 (1H, m),
2.18 (3H, s); 13C NMR (125 MHz, d-DMSO) δ 14.4, 31.0, 31.0,
32.1, 61.6, 67.2, 70.6, 83.2, 87.9, 90.1, 99.4, 114.4, 120.8, 129.3,
143.2, 151.1, 152.0, 157.9, 160.4, 167.3; FABMS (m/z) 460 (M
+ 1)+. Anal. Calcd for C21H25N5O5: C, 54.89; H, 5.48; N, 15.24.
Found: C, 54.66; H, 5.49; N, 15.09.
Preparation of the ODN 12a-g,k. To a solution of ODN
11 (0.97 µmol, 1 mL) was added a solution of magnesium
monoperphthalate (MMPP) (2.9 µmol) in carbonate buffer (50
22 J. Org. Chem., Vol. 70, No. 1, 2005